JP2019514855A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019514855A5 JP2019514855A5 JP2018551137A JP2018551137A JP2019514855A5 JP 2019514855 A5 JP2019514855 A5 JP 2019514855A5 JP 2018551137 A JP2018551137 A JP 2018551137A JP 2018551137 A JP2018551137 A JP 2018551137A JP 2019514855 A5 JP2019514855 A5 JP 2019514855A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- weight
- pharmaceutically active
- binding polypeptide
- active binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023017273A JP7496906B2 (ja) | 2016-03-31 | 2023-02-08 | 組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16163178.3 | 2016-03-31 | ||
| EP16163178 | 2016-03-31 | ||
| PCT/EP2017/057775 WO2017167997A1 (en) | 2016-03-31 | 2017-03-31 | Compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023017273A Division JP7496906B2 (ja) | 2016-03-31 | 2023-02-08 | 組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019514855A JP2019514855A (ja) | 2019-06-06 |
| JP2019514855A5 true JP2019514855A5 (enExample) | 2020-05-14 |
| JP7224917B2 JP7224917B2 (ja) | 2023-02-20 |
Family
ID=55646428
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018551137A Active JP7224917B2 (ja) | 2016-03-31 | 2017-03-31 | 組成物 |
| JP2023017273A Active JP7496906B2 (ja) | 2016-03-31 | 2023-02-08 | 組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023017273A Active JP7496906B2 (ja) | 2016-03-31 | 2023-02-08 | 組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10772839B2 (enExample) |
| EP (1) | EP3435982A1 (enExample) |
| JP (2) | JP7224917B2 (enExample) |
| KR (1) | KR102376369B1 (enExample) |
| CN (2) | CN117243904A (enExample) |
| AU (2) | AU2017240190A1 (enExample) |
| CA (2) | CA3019482A1 (enExample) |
| IL (1) | IL261792B (enExample) |
| SG (1) | SG11201807402PA (enExample) |
| WO (2) | WO2017167997A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006249144B2 (en) * | 2005-05-18 | 2011-11-17 | Ablynx Nv | Improved NanobodiesTM against Tumor Necrosis Factor-alpha |
| AU2016239949A1 (en) | 2015-03-31 | 2017-09-07 | Sorriso Pharmaceuticals, Inc. | Peptide construct having a protease-cleavable linker |
| EP3277719B1 (en) * | 2015-03-31 | 2022-03-16 | Sorriso Pharmaceuticals, Inc. | Polypeptides |
| WO2016156468A1 (en) | 2015-03-31 | 2016-10-06 | Vhsquared Limited | Polypeptides |
| EP3435982A1 (en) | 2016-03-31 | 2019-02-06 | VHsquared Limited | Compositions |
| WO2018060453A1 (en) * | 2016-09-30 | 2018-04-05 | Vhsquared Limited | Compositions |
| AU2017378393B2 (en) | 2016-12-14 | 2023-03-09 | Bt Bidco, Inc. | Treatment of a disease of the gastrointestinal tract with a TNF inhibitor |
| CA3054632A1 (en) * | 2017-03-30 | 2018-10-04 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device |
| EP3459527B1 (en) * | 2017-09-20 | 2022-11-23 | Tillotts Pharma Ag | Method for preparing a solid dosage form comprising antibodies by wet granulation, extrusion and spheronization |
| US20230312700A1 (en) | 2018-06-20 | 2023-10-05 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a tnf inhibitor |
| US11291654B2 (en) * | 2018-09-13 | 2022-04-05 | Syneurx International (Taiwan) Corp. | Formulations of cycloserine compounds and applications thereof |
| CN113348011B (zh) | 2018-11-19 | 2023-04-18 | 比奥拉治疗股份有限公司 | 用生物治疗剂治疗疾病的方法和装置 |
| WO2020144164A1 (en) | 2019-01-07 | 2020-07-16 | Bactolife Aps | Pathogen binding proteins |
| WO2020243393A1 (en) * | 2019-05-30 | 2020-12-03 | Vta Labs, Llc | Design of a single oral delivery system containing a monoclonal antibody for the simultaneous treatment of chron's disease and ulcerative colitis |
| CA3144566A1 (en) | 2019-06-21 | 2020-12-24 | Sorriso Pharmaceuticals, Inc. | Polypeptides |
| US12570736B2 (en) | 2019-06-21 | 2026-03-10 | Sorriso Pharmaceuticals, Inc. | Compositions |
| JP7692844B2 (ja) | 2019-06-21 | 2025-06-16 | ソリッソ ファーマシューティカルズ，インク． | ポリペプチド |
| CN121197633A (zh) | 2019-12-13 | 2025-12-26 | 比特比德科有限责任公司 | 用于将治疗剂递送至胃肠道的可摄取装置 |
| CN115605485A (zh) * | 2020-05-18 | 2023-01-13 | 深圳市塔吉瑞生物医药有限公司（Cn） | 大环化合物的固体形式及其制备和用途 |
| CN113768051B (zh) * | 2020-06-09 | 2024-03-19 | 中粮营养健康研究院有限公司 | 饲料添加剂及其制备方法和其在饲料中的应用以及替抗饲料 |
| GB202017863D0 (en) * | 2020-11-12 | 2020-12-30 | Intract Pharma Ltd | Novel compositions |
| MX2023012437A (es) * | 2021-04-22 | 2023-11-07 | Civi Biopharma Inc | Administracion oral de oligonucleotidos. |
| WO2024163874A2 (en) * | 2023-02-03 | 2024-08-08 | Avexegen Therapeutics, Inc. | Stable and controlled release formulations of neuregulin-4 analogs |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2010126A (en) | 1934-03-19 | 1935-08-06 | Frank L Mclaughlin | Measuring and dispensing can |
| AU664561B2 (en) | 1991-06-21 | 1995-11-23 | University Of Cincinnati, The | Orally administrable therapeutic proteins and method of making |
| US5780028A (en) * | 1993-09-20 | 1998-07-14 | Anadis Ltd. | Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition |
| CN1116898C (zh) * | 2000-02-21 | 2003-08-06 | 湖北楚冠实业股份有限公司 | 一种口服免疫球蛋白制剂及其制备方法 |
| EP1558645B1 (en) | 2002-11-08 | 2011-07-27 | Ablynx N.V. | Stabilized single domain antibodies in pharmaceutical composition adapted for inhalation |
| US8007827B2 (en) * | 2004-04-02 | 2011-08-30 | Impax Laboratories, Inc. | Pharmaceutical dosage forms having immediate release and/or controlled release properties |
| MX2007006086A (es) * | 2004-11-25 | 2007-07-11 | Unilever Nv | Anticuerpos de cadena pesada y de dominio. |
| JP2008543839A (ja) | 2005-06-14 | 2008-12-04 | アムジェン インコーポレーテッド | 自己緩衝タンパク質製剤 |
| US20080026820A1 (en) * | 2006-07-05 | 2008-01-31 | Aruze Gaming America, Inc. | Slot machine and playing method thereof |
| EP2081555A2 (en) | 2006-09-12 | 2009-07-29 | Cosmo Technologies Ltd. | Pharmaceutical compositions for the oral or rectal administration of protein substances |
| WO2008039761A2 (en) | 2006-09-25 | 2008-04-03 | Medimmune, Llc. | Stabilized antibody formulations and uses thereof |
| US20080145420A1 (en) | 2006-12-13 | 2008-06-19 | Simon Michael R | HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES |
| PT2079445E (pt) * | 2007-02-20 | 2016-02-29 | Allergan Pharmaceuticals Internat Ltd | Composições de enzimas digestivas estáveis |
| EP2061440A2 (en) * | 2007-04-04 | 2009-05-27 | Sigmoid Pharma Limited | A pharmaceutical composition of tacrolimus |
| US20080260820A1 (en) | 2007-04-19 | 2008-10-23 | Gilles Borrelly | Oral dosage formulations of protease-resistant polypeptides |
| GB0724331D0 (en) | 2007-12-13 | 2008-01-23 | Domantis Ltd | Compositions for pulmonary delivery |
| US20100239682A1 (en) | 2007-09-17 | 2010-09-23 | Antoine Andremont | Colonic delivery of antimicrobial agents |
| DK3354276T3 (da) | 2007-11-13 | 2020-03-30 | Meritage Pharma Inc | Sammensætninger til behandlingen af gastrointestinal inflammation |
| RU2481824C2 (ru) | 2008-10-29 | 2013-05-20 | Аблинкс Н.В | Препараты однодоменных антигенсвязывающих молекул |
| US9056050B2 (en) * | 2009-04-13 | 2015-06-16 | Curemark Llc | Enzyme delivery systems and methods of preparation and use |
| CN101964403A (zh) | 2009-07-23 | 2011-02-02 | 比克国际(天津)有限公司 | 一种电池组的封装方法及电池组 |
| US20130012916A1 (en) | 2010-02-11 | 2013-01-10 | Glide Pharmaceutical Technologies Limited | Delivery of immunoglobulin variable domains and constructs thereof |
| SG184355A1 (en) | 2010-03-01 | 2012-11-29 | Progenics Pharm Inc | Concentrated protein formulations and uses thereof |
| CN105168174B (zh) | 2010-03-10 | 2019-01-08 | 拉尼医疗有限公司 | 用于利用可吞咽式药剂递送装置递送到肠道内腔中的治疗剂制剂 |
| WO2012130872A1 (en) | 2011-03-28 | 2012-10-04 | Ablynx Nv | Method for producing solid formulations comprising immunoglobulin single variable domains |
| AU2012250924B2 (en) | 2011-05-02 | 2017-05-25 | Immunomedics, Inc. | Ultrafiltration concentration of allotype selected antibodies for small-volume administration |
| SI2849723T1 (sl) | 2012-05-18 | 2018-09-28 | Genentech, Inc. | Formulacije z visoko koncentracijo monoklonskih protiteles |
| EP2887960A2 (en) * | 2012-08-21 | 2015-07-01 | Glaxo Group Limited | Compositions comprising a single variable domain and camostat mesylate (cm) |
| AU2014229282B2 (en) | 2013-03-15 | 2017-02-02 | Glaxosmithkline Intellectual Property (No.2) Limited | Low concentration antibody formulations |
| US20160228371A1 (en) | 2013-10-18 | 2016-08-11 | Abbvie Inc. | Stable solid units and methods of making the same |
| WO2015176031A2 (en) | 2014-05-15 | 2015-11-19 | Incube Labs, Llc | Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins |
| FR3026012B1 (fr) * | 2014-09-23 | 2017-12-01 | Soc D'exploitation De Produits Pour Les Industries Chimiques Seppic | Administration par voie orale d'au moins une substance active pharmaceutique et/ou antigenique |
| EP3277719B1 (en) * | 2015-03-31 | 2022-03-16 | Sorriso Pharmaceuticals, Inc. | Polypeptides |
| WO2016156468A1 (en) | 2015-03-31 | 2016-10-06 | Vhsquared Limited | Polypeptides |
| EP3435982A1 (en) | 2016-03-31 | 2019-02-06 | VHsquared Limited | Compositions |
-
2017
- 2017-03-31 EP EP17716044.7A patent/EP3435982A1/en active Pending
- 2017-03-31 WO PCT/EP2017/057775 patent/WO2017167997A1/en not_active Ceased
- 2017-03-31 AU AU2017240190A patent/AU2017240190A1/en not_active Abandoned
- 2017-03-31 JP JP2018551137A patent/JP7224917B2/ja active Active
- 2017-03-31 SG SG11201807402PA patent/SG11201807402PA/en unknown
- 2017-03-31 CA CA3019482A patent/CA3019482A1/en active Pending
- 2017-04-03 KR KR1020187029576A patent/KR102376369B1/ko active Active
- 2017-04-03 CA CA3053757A patent/CA3053757A1/en not_active Abandoned
- 2017-04-03 CN CN202311230166.8A patent/CN117243904A/zh active Pending
- 2017-04-03 WO PCT/MT2017/000001 patent/WO2017171535A2/en not_active Ceased
- 2017-04-03 CN CN201780020634.5A patent/CN109152738B/zh active Active
-
2018
- 2018-09-16 IL IL261792A patent/IL261792B/en unknown
- 2018-09-25 US US16/140,843 patent/US10772839B2/en active Active
-
2020
- 2020-08-07 US US16/988,506 patent/US10980748B2/en active Active
-
2023
- 2023-01-24 AU AU2023200377A patent/AU2023200377B2/en active Active
- 2023-02-08 JP JP2023017273A patent/JP7496906B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11207270B2 (en) | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances | |
| US20100330129A1 (en) | Gastroresistant Pharmaceutical Formulations Containing Rifaximin | |
| CN109310642B (zh) | 美沙拉嗪的口服药物组合物 | |
| CN108289848A (zh) | 包含urat1的有效抑制剂的药物组合物 | |
| WO2006070781A1 (ja) | 塩基性薬物又はその塩を含有するマトリックス型徐放性製剤およびその製造方法 | |
| JP2012518655A (ja) | プロトンポンプ阻害剤を含む制御放出組成物 | |
| CN101511346A (zh) | 可编制的漂浮递送技术 | |
| JPH07223970A (ja) | 消化管内適所放出製剤 | |
| JP2014501267A (ja) | メサラジン制御放出用の経口用医薬錠剤および前記錠剤を得るための製法 | |
| WO2023047274A1 (en) | Extended release pharmaceutical compositions of dydrogesterone | |
| US20070122480A1 (en) | Sustained release formulations | |
| TWI688411B (zh) | 腸溶錠 | |
| JP6902043B2 (ja) | フマル酸ジメチルを含む医薬ビーズ製剤 | |
| RU2738114C2 (ru) | Пероральные фармацевтические композиции никотинамида | |
| US20110086102A1 (en) | Delayed release compositions | |
| US20090028944A1 (en) | Pharmaceutical compositions comprising mesalamine | |
| CN113382720A (zh) | 用于美沙拉嗪或其衍生物施用的固体口服药物组合物 | |
| EP3796908B1 (en) | Controlled release propiverine formulations | |
| US20230181545A1 (en) | Controlled-release pharmaceutical formulations for treatment of intestinal infections | |
| WO2009047800A2 (en) | Oral controlled release composition of carvedilol | |
| WO2011046546A1 (en) | Delayed release compositions | |
| CA2750611A1 (en) | Chronotherapeutic pharmaceutical composition |